Opportunistic candidal infections in patients infected with human immunodeficiency virus: prevention issues and priorities.
about
Interventions for the management of esophageal candidiasis in immunocompromised patientsInterventions for prevention and treatment of vulvovaginal candidiasis in women with HIV infectionEnhanced extracellular production of aspartyl proteinase, a virulence factor, by Candida albicans isolates following growth in subinhibitory concentrations of fluconazole.Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infectionFungal infections associated with HIV infection.Antifungal prophylaxis during neutropenia and immunodeficiencyImmunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.An in vitro study of antifungal drug susceptibility of Candida species isolated from human immunodeficiency virus seropositive and human immunodeficiency virus seronegative individuals in Lucknow population Uttar PradeshRole of posaconazole in the management of oropharyngeal and esophageal candidiasisSystemic Candida infections.Rapid PCR test for discriminating between Candida albicans and Candida dubliniensis isolates using primers derived from the pH-regulated PHR1 and PHR2 genes of C. albicans.Posaconazole for the management of mucosal candidiasis.Options for the management of mucosal candidiasis in patients with AIDS and HIV infection.A study of antifungal drug sensitivity of Candida isolated from human immunodeficiency virus infected patients in Chennai, South India.
P2860
Q24188301-BEE50FCA-A81C-4333-BC44-4811818A3006Q24234875-B139CDE9-6E43-405A-82BA-EF95CCBE0B9CQ33979398-EC509734-366A-45FE-902D-7B04A70429A1Q34633796-B403601F-3ED8-4054-937C-39BEE582EC3BQ34775235-452BF4EC-A16E-4651-87B1-5EE0F6F0F48AQ35374928-BED308FE-FC18-4647-8133-C040B3824D69Q35920633-40E76E6C-A678-49E5-9E67-D4DA09DA7F93Q36180176-53AD7381-7E03-40FA-B135-3A792D3226EBQ36642964-CB40B57B-459E-460F-86AF-AEFB4F3656A9Q36987671-9DAB7F06-3689-4F9A-B678-5D081E32FB82Q39448963-2F2E52DF-F0E3-4B68-9BF7-3376D3229E51Q40188971-4A8D2F9D-970B-439D-B6AA-A74BA81F212AQ40827662-843903EE-71FB-4319-A6BF-1E69BFE5090CQ41958812-21D71104-2D4E-4727-A646-F113BC10833A
P2860
Opportunistic candidal infections in patients infected with human immunodeficiency virus: prevention issues and priorities.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Opportunistic candidal infecti ...... vention issues and priorities.
@en
type
label
Opportunistic candidal infecti ...... vention issues and priorities.
@en
prefLabel
Opportunistic candidal infecti ...... vention issues and priorities.
@en
P1476
Opportunistic candidal infecti ...... vention issues and priorities.
@en
P2093
P304
P356
10.1093/CLINIDS/21.SUPPLEMENT_1.S99
P407
P478
21 Suppl 1
P577
1995-08-01T00:00:00Z